If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
5,085.00    70.00 (1.40%)
Bid:
5,100.00
Ask:
5,105.00
Spread: 5.00 (0.098%)
Market Cap: £2.37b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

20 Mar 2013 17:36

RNS Number : 5039A
Morgan Sindall Group PLC
20 March 2013
 



 Morgan Sindall Group plc

 ('the Company')

 

Notification of Transactions by Directors

 

 

Executive Remuneration Plan 2005 (the 'Plan')

 

On 17 March 2010 the Company granted awards under the Plan to its executive directors in respect of ordinary shares of 5p each in the Company ('shares'). These awards took the form of performance shares or, at the election of each individual, options to subscribe for shares and were subject to an absolute earnings per share performance target for the year ended 31 December 2012. Following completion of the performance period, the Company announces that 48.8% of the performance share awards have vested and that 46.3% of the share options have become exercisable. The remainder of the awards which have not vested or become exercisable has now lapsed.

 

Performance share awards

The Company therefore announces the number of shares which were transferred to Paul Whitmore on 18 March 2013. These shares include additional shares representing the dividend equivalent to which he is entitled under the Plan. These shares were satisfied from market purchased shares held in the Morgan Sindall Employee Benefit Trust.

 

In addition, he has disposed of a proportion of the shares vesting in order to fund the tax and national insurance contribution payable in respect of them.

 

Name of Director

Number of performance shares awarded

17 March 2010

 

 

48.8% of performance share awards vesting

Number of dividend equivalent shares

Total number of shares vested

Number of shares disposed

 

 

 

Number of performance share awards lapsed

Total number of shares transferred

Paul Whitmore

36,486

17,805

3,052

20,857

10,846

18,681

10,011

 

The market value of a share on 18 March 2013 was 550.5p and the shares disposed were sold to the Morgan Sindall Employee Benefit Trust at that price.

 

Share Options

The Company also announces the number of share options which became exercisable by John Morgan from 18 March 2013.

 

Name of Director

Number of options granted

17 March 2010

 

46.3% of share options becoming exercisable

Exercise price

 

 

 

 

Number of share options lapsed

John Morgan

229,728

106,364

£5.55

123,364

 

 

 

Following these transactions, the interests (all of which are beneficial) of the above directors in the share capital of the Company are as follows:

 

Name of Director

Beneficial interest in shares

% issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

John Morgan

4,497,508

10.40

496,930

149,410

Paul Whitmore

72,851

0.17

1,814

141,817

 

This notification relates to transactions notified in accordance with both Disclosure Rule 3.1.4R (1) (a) and Disclosure Rule 3.1.4R (1) (c).

 

Enquiries:

Mary Nettleship Tel: 020 7307 9200

Company Secretary

 

20 March 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFVDVEIIFIV
Date   Source Headline
2nd Jul 20267:00 amRNSNotice of Half Year Results
1st Jul 20269:36 amRNSTotal Voting Rights
23rd Jun 20262:59 pmRNSDirector/PDMR Shareholding
16th Jun 20261:05 pmRNSAdmission to Trading
12th Jun 202610:25 amRNSDirector/PDMR Shareholding
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.